Subsequently, we performed IHC staining for RPAP2 in tissue microarrays comprising 101 HCC samples and found that patients with high RPAP2 protein levels exhibited significantly worse survival than those with low RPAP2 levels (Figure 1E). Here, RPAP2 is linked to hepatocellular carcinoma.